Abstract
Although genetics contributes significantly to smoking addiction, the susceptibility genes and variants underlying it remain largely unknown. Many years of genome-wide and candidate gene-based association studies have implicated a number of genes and biological pathways in the etiology of nicotine and other addictions. In this chapter, we focus on current evidence, primarily from human genetic studies, supporting the involvement of variants in the serotonin transporter and receptor genes in the etiology of nicotine dependence (ND) based on both individual SNP- and haplotype-based association analysis, as well as gene-by-gene interaction studies. Current efforts aim not only to replicate these findings in independent samples but also to identify which variant(s) contributes to the etiology of ND and through what molecular mechanisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arinami T, Ohtsuki T, Yamakawa-Kobayashi K, Amemiya H, Fujiwara H, Kawata K, Ishiguro H, Hamaguchi H (1999) A synergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD. Thromb Haemost 81:853–856
Awtry TL, Werling LL (2003) Acute and chronic effects of nicotine on serotonin uptake in prefrontal cortex and hippocampus of rats. Synapse 50:206–211. https://doi.org/10.1002/syn.10259
Barnes NM, Hales TG, Lummis SC, Peters JA (2009) The 5-HT3 receptor--the relationship between structure and function. Neuropharmacology 56:273–284. https://doi.org/10.1016/j.neuropharm.2008.08.003
Breitinger HG, Geetha N, Hess GP (2001) Inhibition of the serotonin 5-HT3 receptor by nicotine, cocaine, and fluoxetine investigated by rapid chemical kinetic techniques. Biochemistry 40:8419–8429
Cravchik A, Goldman D (2000) Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters. Arch Gen Psychiatry 57:1105–1114
Dougherty JJ, Nichols RA (2009) Cross-regulation between colocalized nicotinic acetylcholine and 5-HT3 serotonin receptors on presynaptic nerve terminals. Acta Pharmacol Sin 30:788–794. https://doi.org/10.1038/aps.2009.62
Enoch MA, Gorodetsky E, Hodgkinson C, Roy A, Goldman D (2011) Functional genetic variants that increase synaptic serotonin and 5-HT3 receptor sensitivity predict alcohol and drug dependence. Mol Psychiatry 16:1139–1146. https://doi.org/10.1038/mp.2010.94
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229
Gatt JM, Williams LM, Schofield PR, Dobson-Stone C, Paul RH, Grieve SM, Clark CR, Gordon E, Nemeroff CB (2010) Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood. Depress Anxiety 27:752–759. https://doi.org/10.1002/da.20726
Gerra G, Garofano L, Zaimovic A, Moi G, Branchi B, Bussandri M, Brambilla F, Donnini C (2005) Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am J Med Genet B Neuropsychiatr Genet 135:73–78
Grant KA (1995) The role of 5-HT3 receptors in drug dependence. Drug Alcohol Depend 38:155–171
Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621–2624
Heils A, Mossner R, Lesch KP (1997) The human serotonin transporter gene polymorphism – basic research and clinical implications. J Neural Transm 104:1005–1014
Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD, Munafo MR, Tyndale RF (2010) Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clin Pharmacol Ther 88:779–791. doi: clpt2010175 [pii] 151038/clpt.2010.175
Hu S, Brody CL, Fisher C, Gunzerath L, Nelson ML, Sabol SZ, Sirota LA, Marcus SE, Greenberg BD, Murphy DL, Hamer DH (2000) Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol Psychiatry 5:181–188
Ishikawa H, Ohtsuki T, Ishiguro H, Yamakawa-Kobayashi K, Endo K, Lin YL, Yanagi H, Tsuchiya S, Kawata K, Hamaguchi H, Arinami T (1999) Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol Biomark Prev 8:831–833
Jasinska AJ, Chua HF, Ho SS, Polk TA, Rozek LS, Strecher VJ (2012) Amygdala response to smoking-cessation messages mediates the effects of serotonin transporter gene variation on quitting. NeuroImage 60:766–773. https://doi.org/10.1016/j.neuroimage.2011.12.064
Krzywkowski K, Davies PA, Feinberg-Zadek PL, Brauner-Osborne H, Jensen AA (2008) High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor. Proc Natl Acad Sci U S A 105:722–727. https://doi.org/10.1073/pnas.0708454105
Lerman C, Shields PG, Audrain J, Main D, Cobb B, Boyd NR, Caporaso N (1998) The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomark Prev 7:253–255
Lerman C, Caporaso NE, Audrain J, Main D, Boyd NR, Shields PG (2000) Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol Psychiatry 5:189–192
Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, Riederer P (1994) Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 95:157–162
Lessov-Schlaggar CN, Pergadia ML, Khroyan TV, Swan GE (2008) Genetics of nicotine dependence and pharmacotherapy. Biochem Pharmacol 75:178–195
Li MD (2010) Grand challenges and opportunities for molecular psychiatry research: a perspective. Front Psych 1:2. https://doi.org/10.3389/fpsyt.2010.00002
Li MD, Cheng R, Ma JZ, Swan GE (2003) A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98:23–31
Li MD, Lou XY, Chen G, Ma JZ, Elston RC (2008) Gene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence. Biol Psychiatry 64:951–957
Miyake A, Mochizuki S, Takemoto Y, Akuzawa S (1995) Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Mol Pharmacol 48:407–416
Nayak SV, Ronde P, Spier AD, Lummis SC, Nichols RA (2000) Nicotinic receptors co-localize with 5-HT(3) serotonin receptors on striatal nerve terminals. Neuropharmacology 39:2681–2690
Niesler B, Flohr T, Nothen MM, Fischer C, Rietschel M, Franzek E, Albus M, Propping P, Rappold GA (2001) Association between the 5′ UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 11:471–475
Patkar AA, Gopalakrishnan R, Berrettini WH, Weinstein SP, Vergare MJ, Leone FT (2003) Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers. Psychopharmacology 166:221–227. https://doi.org/10.1007/s00213-002-1353-2
Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A 90:2542–2546
Semba J, Wakuta M (2008) Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion. Psychiatry Clin Neurosci 62:435–441. https://doi.org/10.1111/j.1440-1819.2008.01822.x
Seneviratne C, Huang W, Ait-Daoud N, Li MD, Johnson BA (2009) Characterization of a functional polymorphism in the 3′ UTR of SLC6A4 and its association with drinking intensity. Alcohol Clin Exp Res 33:332–339. ACER837 [pii] 341111/j.1530-0277.2008.00837.x
Slotkin TA, Seidler FJ (2010) Mimicking maternal smoking and pharmacotherapy of preterm labor: interactions of fetal nicotine and dexamethasone on serotonin and dopamine synaptic function in adolescence and adulthood. Brain Res Bull 82:124–134. https://doi.org/10.1016/j.brainresbull.2010.02.015
Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, Maciejewski PK, O’Malley S, Innis RB (2001) Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 41:275–284. https://doi.org/10.1002/syn.1084
Steen KV (2012) Travelling the world of gene-gene interactions. Brief Bioinform 13:1–19. https://doi.org/10.1093/bib/bbr012
Sullivan PF, Kendler KS (1999) The genetic epidemiology of smoking. Nicotine Tob Res. 1 Suppl 2: S51–7.; discussion S69–70
Swan GE, Hudmon KS, Jack LM, Hemberger K, Carmelli D, Khroyan TV, Ring HZ, Hops H, Andrews JA, Tildesley E, McBride D, Benowitz N, Webster C, Wilhelmsen KC, Feiler HS, Koenig B, Caron L, Illes J, Cheng LS (2003) Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. Cancer Epidemiol Biomark Prev 12:994–1005
Trummer O, Koppel H, Wascher TC, Grunbacher G, Gutjahr M, Stanger O, Ramschak-Schwarzer S, Boehm BO, Winkelmann BR, Marz W, Renner W (2006) The serotonin transporter gene polymorphism is not associated with smoking behavior. Pharmacogenomics J 6:397–400. https://doi.org/10.1038/sj.tpj.6500389
Vallender EJ, Priddy CM, Hakim S, Yang H, Chen GL, Miller GM (2008) Functional variation in the 3′ untranslated region of the serotonin transporter in human and rhesus macaque. Genes Brain Behav 7:690–697. https://doi.org/10.1111/j.1601-183X.2008.00407.x
van der Zwaluw CS, Engels RC (2009) Gene-environment interactions and alcohol use and dependence: current status and future challenges. Addiction 104:907–914. doi: ADD2563 [pii] 431111/j.1360-0443.2009.02563.x
Walstab J, Rappold G, Niesler B (2010) 5-HT(3) receptors: role in disease and target of drugs. Pharmacol Ther 128:146–169. https://doi.org/10.1016/j.pharmthera.2010.07.001
WHO (2008) Report on the global tobacco epidemic, 2008: the MPOWER package. World Health Organization, Geneva
Yang Z, Seneviratne C, Wang S, Ma JZ, Payne TJ, Wang J, Li MD (2013) Serotonin transporter and receptor genes significantly impact nicotine dependence through genetic interactions in both European American and African American smokers. Drug Alcohol Depend 129:217–225. https://doi.org/10.1016/j.drugalcdep.2012.12.007
Zuk O, Hechter E, Sunyaev SR, Lander ES (2012) The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci U S A 109:1193–1198. https://doi.org/10.1073/pnas.1119675109
Acknowledgments
This chapter was modified from the work reported by our group in New Developments in Serotonin Research (edited by Li, M.D. pp. 1–26, Nova Science Publishers Inc., 2015). The related contents are re-used with permission.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Li, M.D. (2018). Significant Contribution of Variants in Serotonin Transporter and Receptor Genes to Smoking Dependence. In: Tobacco Smoking Addiction: Epidemiology, Genetics, Mechanisms, and Treatment. Springer, Singapore. https://doi.org/10.1007/978-981-10-7530-8_9
Download citation
DOI: https://doi.org/10.1007/978-981-10-7530-8_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7529-2
Online ISBN: 978-981-10-7530-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)